Taipei, Oct. 24 (CNA) Taiwan’s Medigen Vaccine Biologics Corp. will provide a free polymerase chain reaction (PCR) testing service to recipients of its protein-based COVID-19 vaccine who wish to travel to Japan until the end of 2022, the company announced Monday.
Currently, countries and areas that accept Medigen as proof of vaccination include Indonesia, Palau, New Zealand, Belize, Somaliland, Thailand, Estonia, Paraguay, Malaysia and Saint Kitts and Nevis.
Japan, one of the most popular destinations among Taiwanese travelers, is not on the list, and Medigen recipients wanting to go there will need to instead provide proof of a negative PCR test upon entry.
In a statement Monday, Medigen said it will provide recipients of its domestically made vaccine who wish to travel to Japan free PCR testing from Oct. 28 until the end of 2022.
The company said the service complements the Central Epidemic Command Center’s initiative to provide Medigen recipients with additional vaccine shots that have been granted Emergency Use Listing (EUL) by the World Health Organization (WHO).
Medigen said it decided to launch the service after considering its company image, social responsibility and interests of its shareholders.
The service will be provided in hospitals in northern, central and southern Taiwan, and details on the three hospitals will soon be released on the company’s website, it said, as will plans to expand the service to more locations if necessary.
(By Han Ting-ting and James Lo)


Shop Sephari